ID27483A - Metoda terapi gen - Google Patents

Metoda terapi gen

Info

Publication number
ID27483A
ID27483A IDW20002711A ID20002711A ID27483A ID 27483 A ID27483 A ID 27483A ID W20002711 A IDW20002711 A ID W20002711A ID 20002711 A ID20002711 A ID 20002711A ID 27483 A ID27483 A ID 27483A
Authority
ID
Indonesia
Prior art keywords
therapy method
general therapy
general
therapy
Prior art date
Application number
IDW20002711A
Other languages
English (en)
Indonesian (id)
Inventor
Martin Braddock
Callum Jeffrey Campbell
Jean-Luc Schwachtgen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en
Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en
Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en
Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID27483A publication Critical patent/ID27483A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW20002711A 1998-06-02 1999-06-02 Metoda terapi gen ID27483A (id)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
GBGB9815035.2A GB9815035D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819846.8A GB9819846D0 (en) 1998-09-12 1998-09-12 Gene therapy method
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation

Publications (1)

Publication Number Publication Date
ID27483A true ID27483A (id) 2001-04-12

Family

ID=27451790

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002711A ID27483A (id) 1998-06-02 1999-06-02 Metoda terapi gen

Country Status (28)

Country Link
US (1) US6689758B1 (de)
EP (2) EP1083934B1 (de)
JP (1) JP2002516676A (de)
KR (1) KR20010043968A (de)
CN (1) CN1311822A (de)
AP (1) AP2000001999A0 (de)
AT (1) ATE246518T1 (de)
AU (1) AU770497B2 (de)
BR (1) BR9910877A (de)
CA (1) CA2334171A1 (de)
DE (1) DE69910202T2 (de)
DK (1) DK1083934T3 (de)
EA (1) EA200001124A1 (de)
EE (1) EE200000790A (de)
ES (1) ES2205830T3 (de)
HR (1) HRP20000832A2 (de)
HU (1) HUP0103252A3 (de)
ID (1) ID27483A (de)
IL (1) IL139936A0 (de)
IS (1) IS5742A (de)
NO (1) NO20006047L (de)
NZ (1) NZ508505A (de)
PL (1) PL345207A1 (de)
PT (1) PT1083934E (de)
SK (1) SK18322000A3 (de)
TR (2) TR200100348T2 (de)
WO (1) WO1999062561A2 (de)
YU (1) YU75600A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
EP1467207B1 (de) * 2002-01-10 2008-06-04 Takeda Pharmaceutical Company Limited Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
AU2003302337A1 (en) * 2002-12-31 2004-07-29 The Johns Hopkins University Wound healing method and kits
EP1671655A4 (de) * 2003-08-29 2009-08-12 Anges Mg Inc Gentherapie für hauterkrankungen mit nadelfreier spritze
DE10342071B4 (de) * 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko) 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
HRP20150759T1 (hr) 2007-05-11 2015-08-14 Adynxx, Inc. Ekspresija gena i bolovi
FR2920158B1 (fr) * 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) * 2007-11-26 2009-05-29 Galderma Res & Dev Modulateurs de egr1 dans le traitement de l'alopecie
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
CN102552938A (zh) * 2012-03-22 2012-07-11 南京大学 Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
CN104487096B (zh) 2012-05-10 2020-09-15 埃迪恩克斯股份有限公司 用于活性成分递送的配制物
CA2957250A1 (en) 2014-08-15 2016-02-18 Adynxx, Inc. Oligonucleotide decoys for the treatment of pain
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763209A (en) 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
AUPN855496A0 (en) 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells

Also Published As

Publication number Publication date
CA2334171A1 (en) 1999-12-09
ES2205830T3 (es) 2004-05-01
HUP0103252A2 (hu) 2001-12-28
EP1083934A2 (de) 2001-03-21
AU770497B2 (en) 2004-02-26
PT1083934E (pt) 2003-12-31
IL139936A0 (en) 2002-02-10
EP1281763A3 (de) 2003-07-09
BR9910877A (pt) 2002-01-22
EP1083934B1 (de) 2003-08-06
WO1999062561A3 (en) 2000-08-03
JP2002516676A (ja) 2002-06-11
WO1999062561A2 (en) 1999-12-09
NZ508505A (en) 2003-04-29
EA200001124A1 (ru) 2001-08-27
CN1311822A (zh) 2001-09-05
NO20006047L (no) 2001-02-01
TR200102985T2 (tr) 2002-06-21
HRP20000832A2 (en) 2001-04-30
EP1281763A2 (de) 2003-02-05
YU75600A (sh) 2004-03-12
NO20006047D0 (no) 2000-11-29
DK1083934T3 (da) 2003-12-01
DE69910202D1 (de) 2003-09-11
HK1034465A1 (en) 2001-10-26
AU4156099A (en) 1999-12-20
KR20010043968A (ko) 2001-05-25
PL345207A1 (en) 2001-12-03
ATE246518T1 (de) 2003-08-15
IS5742A (is) 2000-11-28
DE69910202T2 (de) 2004-06-17
EE200000790A (et) 2002-04-15
HUP0103252A3 (en) 2003-09-29
US6689758B1 (en) 2004-02-10
AP2000001999A0 (en) 2000-12-31
SK18322000A3 (sk) 2001-11-06
TR200100348T2 (tr) 2001-07-23

Similar Documents

Publication Publication Date Title
IS8368A (is) Ný aðferð
FI971620A7 (fi) Autentikointimenetelmä
DE69938817D1 (de) Erstellungsverfahren
ID27841A (id) Turunan-turunan biaril terapeutik
DE69916691D1 (de) Herzschrittmacher
ID24118A (id) Terapi gabungan
ID24275A (id) Terapi kombinasi
FI20000863L (fi) Uusi hoitomenetelmä
ID29128A (id) Gen untuk biosintesis epotilon
ID27483A (id) Metoda terapi gen
IS5106A (is) Ný aðferð
FI980488A7 (fi) Uusi diagnostinen menetelmä
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
ID24444A (id) GEN dtsR PEKA-TEMPERATUR
ID16924A (id) Metode perlakuan poliolefin
DE69903035D1 (de) Erwärmungsverfahren
NO20012301D0 (no) Ny fremgangsmåte for behandling
FI981242A0 (fi) Menetelmä kefalokuvien ottamiseksi
FI982722L (fi) Diagnostinen menetelmä
FI974067A0 (fi) Process foer cellulasbehandling
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
ID26641A (id) Metoda pengobatan
SE9802791D0 (sv) Behandlingsmetod